Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests

INTRODUCTION: Numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological tests exists commercially; however, their performance using clinical samples is limited. Although insufficient to detect SARS-CoV-2 in the early phase of infection, antibody assays can be of great use for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Chemother
Autors principals: Ashizawa, Nobuyuki, Takazono, Takahiro, Ohyama, Kaname, Nagasaki, Yoji, Okamoto, Masaki, Hirayama, Tatsuro, Takahashi, Kensuke, Yamanashi, Hirotomo, Tashiro, Masato, Hosogaya, Naoki, Tanaka, Takeshi, Yamamoto, Kazuko, Fukuda, Yuichi, Imamura, Yoshifumi, Kawanami, Toshinori, Miyazaki, Taiga, Sawai, Toyomitsu, Fukushima, Kiyoyasu, Yatera, Kazuhiro, Yanagihara, Katsunori, Izumikawa, Koichi, Mukae, Hiroshi
Format: Artigo
Idioma:Inglês
Publicat: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7959261/
https://ncbi.nlm.nih.gov/pubmed/33781691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiac.2021.03.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars